Oncology
Improving Knowledge and Overcoming Barriers to Optimal Therapy in Metastatic Renal Cell Carcinoma
City of Hope
Approved: June 2013
Grant Period: July 2013 – July 2015
Proposal
Improving Knowledge and Overcoming Barriers to Optimal Therapy in Metastatic Renal Cell Carcinoma
The two main objectives of this initiative are to:
- Increase physician adherence to National Comprehensive Cancer Network (NCCN), dosing recommendations for metastatic renal cell carcinoma patients treated in the community
- As optimal dosing can significantly impact patient outcomes, oncologists and urologists’ lack of knowledge regarding recommended guidelines on dosing may reduce treatment efficacy
- Introduction of newer, more efficacious and well-tolerated therapies will enable community oncologists to manage various cancer patient at the local level, thereby decreasing the number of unnecessary referrals
- Improve access and visibility of clinical trials for metastatic renal cell carcinoma patients in the community
- As advancements in oncology research continue to unfold, the role of clinical trials will remain a significant part of patient management
- Lack of awareness by clinicians regarding available clinical trial enrollment opportunities may limit patients’ access to all available treatment options